Brovana and Perforomist will be the first long-acting beta-2 agonists that come in solutions for NEBULIZER use

Brovana and Perforomist will be the first long-acting beta-2 agonists that come in solutions for NEBULIZER use.

Both are approved for treating COPD.

Brovana (arformoterol) is an isomer of formoterol...the long-acting beta-2 agonist in Foradil and Symbicort inhalers.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote